Norjizak Injection: A Critical Risk for Transmitting Blood-Borne Infectious Diseases

Norjizak Injection: A Critical Risk for Transmitting Blood-Borne Infectious Diseases

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Infectious diseases including HIV and viral hepatitis constitute a major health concern with high prevalences among injecting drug users (IDUs) in Iran (1, 2). IDUs that share needles and syringes and practice sexual behaviors are at risk groups for being infected with blo...

norjizak injection: a critical risk for transmitting blood-borne infectious diseases

an emerging trend of methamphetamine injection in iran: a critical target for research on blood-borne infection diseases

Changes in blood-borne infection risk among injection drug users.

BACKGROUND Population-level hepatitis C virus (HCV) infection incidence is a surrogate for community drug-related risk. METHODS We characterized trends in human immunodeficiency virus (HIV) and HCV infection incidence and HCV infection prevalence among injection drug users (IDUs) recruited over 4 periods: 1988-1989, 1994-1995, 1998, and 2005-2008. We calculated HIV and HCV infection incidence...

Prevalence of blood-borne infectious diseases in blood donors in Ghana.

Transfusion-transmissible infections among 808 blood donors in Ghana were investigated in 1999. Antibody seroprevalences of 3.8, 0.7, 8.4, and 13.5%, respectively, for human immunodeficiency virus, human T-cell lymphotrophic virus type 1, hepatitis C virus (HCV), and Treponema pallidum were obtained. The seroprevalence of HCV infection was confirmed to be 0.9% after supplementary testing, and t...